Literature DB >> 12689860

Extracellular ATP signaling in the rabbit lung: erythrocytes as determinants of vascular resistance.

Randy S Sprague1, Jeffrey J Olearczyk, Dana M Spence, Alan H Stephenson, Robert W Sprung, Andrew J Lonigro.   

Abstract

Previously, it was reported that red blood cells (RBCs) are required to demonstrate participation of nitric oxide (NO) in the regulation of rabbit pulmonary vascular resistance (PVR). RBCs do not synthesize NO; hence, we postulated that ATP, present in millimolar amounts in RBCs, was the mediator, which evoked NO synthesis in the vascular endothelium. First, we found that deformation of RBCs, as occurs on passage across the pulmonary circulation with increasing flow rate, evoked increments in ATP release. Here, ATP (300 nM), administered to isolated, salt solution-perfused (PSS) rabbit lungs, decreased total and upstream (arterial) PVR, a response inhibited by NG-nitro-L-arginine methyl ester (L-NAME, 100 microM). In lungs perfused with PSS containing RBCs, L-NAME increased total and upstream PVR. In lungs perfused with PSS containing glibenclamide-treated RBCs, which inhibits ATP release, L-NAME was without effect. Apyrase grade VII (8 U/ml), which degrades ATP to AMP, was without effect on PVR in PSS-perfused lungs. These results are consistent with the hypothesis that ATP, released from RBCs as they traverse the pulmonary circulation, evokes endogenous NO synthesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12689860     DOI: 10.1152/ajpheart.01026.2002

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  39 in total

Review 1.  The touching story of purinergic signaling in epithelial and endothelial cells.

Authors:  Jenny Öhman; David Erlinge
Journal:  Purinergic Signal       Date:  2012-04-24       Impact factor: 3.765

2.  Erythrocyte-dependent regulation of human skeletal muscle blood flow: role of varied oxyhemoglobin and exercise on nitrite, S-nitrosohemoglobin, and ATP.

Authors:  Stéphane P Dufour; Rakesh P Patel; Angela Brandon; Xinjun Teng; James Pearson; Horace Barker; Leena Ali; Ada H Y Yuen; Ryszard T Smolenski; José González-Alonso
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-17       Impact factor: 4.733

3.  Red blood cell membrane fluctuations and shape controlled by ATP-induced cytoskeletal defects.

Authors:  N S Gov; S A Safran
Journal:  Biophys J       Date:  2004-12-21       Impact factor: 4.033

4.  Luminal ATP-induced contraction of rabbit pulmonary arteries and role of purinoceptors in the regulation of pulmonary arterial pressure.

Authors:  Eun Bok Baek; Hae Young Yoo; Su Jung Park; Hyang Sun Kim; Seong Deok Kim; Yung E Earm; Sung Joan Kim
Journal:  Pflugers Arch       Date:  2008-06-10       Impact factor: 3.657

Review 5.  Na(+)/H(+) exchange and hypoxic pulmonary hypertension.

Authors:  John Huetsch; Larissa A Shimoda
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

6.  The Roles of Mitochondrial Damage-Associated Molecular Patterns in Diseases.

Authors:  Kiichi Nakahira; Shu Hisata; Augustine M K Choi
Journal:  Antioxid Redox Signal       Date:  2015-08-17       Impact factor: 8.401

7.  Pannexin 1 is the conduit for low oxygen tension-induced ATP release from human erythrocytes.

Authors:  Meera Sridharan; Shaquria P Adderley; Elizabeth A Bowles; Terrance M Egan; Alan H Stephenson; Mary L Ellsworth; Randy S Sprague
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-09       Impact factor: 4.733

8.  Phosphodiesterase 5 inhibitors augment UT-15C-stimulated ATP release from erythrocytes of humans with pulmonary arterial hypertension.

Authors:  Elizabeth A Bowles; Gina N Moody; Yashaswini Yeragunta; Alan H Stephenson; Mary L Ellsworth; Randy S Sprague
Journal:  Exp Biol Med (Maywood)       Date:  2014-08-14

9.  Phosphodiesterase 3 is present in rabbit and human erythrocytes and its inhibition potentiates iloprost-induced increases in cAMP.

Authors:  Madelyn S Hanson; Alan H Stephenson; Elizabeth A Bowles; Meera Sridharan; Shaquria Adderley; Randy S Sprague
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-27       Impact factor: 4.733

10.  Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action.

Authors:  Lina Nordquist; Fredrik Palm; Bradley T Andresen
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.